About
The webinar provides a comprehensive overview of the latest treatment strategies and guidelines for managing immune-mediated inflammatory diseases (IMIDs), evaluates the real-world efficacy and safety of tofacitinib across diverse patient populations, and features interactive case studies on the practical use of JAK inhibitors in IMID management.
Chairperson & Speaker
Associate Professor Dr Fariz Yahya
Consultant Rheumatologist and Physician,
Universiti Malaya Medical Centre (UMMC), Malaysia
Dr Fariz Yahya is a Consultant Rheumatologist and Physician at UMMC and serves as an Associate Professor at Universiti Malaya Kuala Lumpur. He earned his medical degree from Queen’s University of Belfast in the UK and completed his training in Internal Medicine and Rheumatology at Universiti Malaya. His clinical expertise was further honed during his tenure as a Clinical Research Fellow at the Royal National Hospital for Rheumatic Diseases in Bath, UK.
Dr Yahya's professional contributions extend beyond clinical practice. He serves as the Deputy Treasurer for the Malaysian Society of Rheumatology and was an executive committee for the Arthritis Foundation Malaysia (AFM). His active involvement in international research networks includes membership in the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the Asia Pacific League of Associations for Rheumatology (APLAR) Special Interest Group for Spondyloarthritis.
An accomplished researcher, Dr Yahya has authored numerous peer-reviewed articles and is engaged in clinical trials focusing on psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus (SLE) and rheumatoid arthritis. Additionally, he is currently part of the working group for the APLAR Psoriatic Arthritis Treatment Recommendations and for the Malaysian Clinical Practice Guidelines for Inflammatory Bowel Disease.
Speaker
Dr Anindita Santosa
Consultant Rheumatologist and Medical Director,
Aaria Rheumatology, Singapore
Dr Anindita Santosa earned her medical degree from the Yong Loo Lin School of Medicine at the National University of Singapore. She completed Basic Speciality Training in Internal Medicine and gained membership to the Royal College of Physicians (UK). She then specialized in Rheumatology at Tan Tock Seng Hospital, achieving specialist accreditation and recently obtained a Master’s in Allergy from Imperial College London.
Dr Santosa is proficient in managing various rheumatic conditions, including arthritis, soft tissue rheumatism, osteoporosis, complex connective tissue diseases and systemic vasculitis. Her clinical interests mainly lie in connective tissue diseases, such as SLE, systemic sclerosis and connective tissue disease-associated pulmonary arterial hypertension. Moreover, she is interested in immunologic disorders, including allergic diseases and immunodeficiencies. She is passionate about digital health and leads the SingHealth RheumConnect chatbot project for early diagnosis of autoimmune diseases.
Active in the APLAR, Dr Santosa contributes to digital health discussions and is committed to education as a Clinical Assistant Professor at Duke-NUS. She also serves on the board of the National Arthritis Foundation and the Lupus Association (Singapore), focusing on patient advocacy and health literacy.
What to expect in this webinar?
- Treatment strategies and guidelines recommendations in the management of IMID
- Insights into the efficacy and safety of tofacitinib in diverse patient populations in the real-world setting
- Interactive case sharing on the use of JAK inhibitors in the management of IMID
Oct
2024
Oct
2024
Speakers
